Source:http://linkedlifedata.com/resource/pubmed/id/20691153
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2010-9-6
|
pubmed:abstractText |
Type 1 diabetes (T1D) is caused by a T cell-mediated autoimmune response that leads to the loss of insulin-producing beta cells. The optimal preclinical testing of promising therapies would be aided by a humanized immune-mediated T1D model. We develop this model in NOD-scid IL2rgamma(null) mice. The selective destruction of pancreatic islet beta cells was mediated by human T lymphocytes after an initial trigger was supplied by the injection of irradiated spleen mononuclear cells (SMC) from diabetic nonobese diabetic (NOD) mice. This resulted in severe insulitis, a marked loss of total beta-cell mass, and other related phenotypes of T1D. The migration of human T cells to pancreatic islets was controlled by the beta cell-produced highly conserved chemokine stromal cell-derived factor 1 (SDF-1) and its receptor C-X-C chemokine receptor (CXCR) 4, as demonstrated by in vivo blocking experiments using antibody to CXCR4. The specificity of humanized T cell-mediated immune responses against islet beta cells was generated by the local inflammatory microenvironment in pancreatic islets including human CD4(+) T cell infiltration and clonal expansion, and the mouse islet beta-cell-derived CD1d-mediated human iNKT activation. The selective destruction of mouse islet beta cells by a human T cell-mediated immune response in this humanized T1D model can mimic those observed in T1D patients. This model can provide a valuable tool for translational research into T1D.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1090-2104
|
pubmed:author |
pubmed-author:BrenaR MRM,
pubmed-author:DingeldeinMichaelM,
pubmed-author:GuoChengshanC,
pubmed-author:HoltermanMark JMJ,
pubmed-author:HwangDavidD,
pubmed-author:JainSumitS,
pubmed-author:MazzoneTheodoreT,
pubmed-author:MihailescuDanD,
pubmed-author:PrabhakarBellur SBS,
pubmed-author:SamSusanS,
pubmed-author:SidhwaniSeemaS,
pubmed-author:SkidgelRandal ARA,
pubmed-author:ZhangYongkangY,
pubmed-author:ZhaoYongY
|
pubmed:copyrightInfo |
Copyright 2010 Elsevier Inc. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:day |
3
|
pubmed:volume |
399
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
629-36
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:20691153-Animals,
pubmed-meshheading:20691153-Cell Movement,
pubmed-meshheading:20691153-Chemokine CXCL12,
pubmed-meshheading:20691153-Diabetes Mellitus, Type 1,
pubmed-meshheading:20691153-Disease Models, Animal,
pubmed-meshheading:20691153-Humans,
pubmed-meshheading:20691153-Insulin-Secreting Cells,
pubmed-meshheading:20691153-Leukocytes, Mononuclear,
pubmed-meshheading:20691153-Mice,
pubmed-meshheading:20691153-Mice, Inbred NOD,
pubmed-meshheading:20691153-Mice, SCID,
pubmed-meshheading:20691153-Spleen,
pubmed-meshheading:20691153-T-Lymphocytes,
pubmed-meshheading:20691153-Translational Medical Research
|
pubmed:year |
2010
|
pubmed:articleTitle |
Selective destruction of mouse islet beta cells by human T lymphocytes in a newly-established humanized type 1 diabetic model.
|
pubmed:affiliation |
Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA. yongzhao@uic.edu
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|